Peripheral Vascular Stents Market To Reach $2.97 Billion By 2030

Peripheral Vascular Stents Market Growth & Trends

The global peripheral vascular stents market size is expected to reach USD 2.97 billion by 2030, growing at 7.4% CAGR from 2023 to 2030, according to a new report by Grand View Research, Inc. The market's growth can be attributed to the increasing prevalence of peripheral vascular diseases (PVDs). According to the American Heart Association (AHA) and their Heart Disease and Stroke Statistics - 2022 Update, cardiovascular disease (CVD) was the primary cause of approximately 19.05 million deaths worldwide in 2020. In addition, cerebrovascular diseases were responsible for around 7.08 million deaths globally during the same year. These alarming statistics highlight the significant burden of cardiac diseases and underscore the need for effective interventions such as peripheral vascular stents.

The market growth is further propelled by technological advancements and the continued approval of new products, supported by partnerships and collaborations among key industry players. For instance, Cordis, a renowned cardiovascular technology company, obtained approval from the United States Food and Drug Administration (FDA) in March 2022 for the S.M.A.R.T. RADIANZ Vascular Stent System. This self-expanding stent is specifically designed for radial peripheral procedures. The recently approved BRITE TIP RADIANZ Guiding Sheath and SABERX RADIANZ PTA Catheter complement this system. These innovative solutions optimize radial access, deliver remarkable outcomes, and enhance patient satisfaction.

 Request a free sample copy or view report summary: Peripheral Vascular Stents Market Report

Peripheral Vascular Stents Market Report Highlights

• In 2022, the drug-eluting stents (DES) segment accounted for the largest share of 60.52% of the market. DES effectively reduces restenosis compared to bare metal stents (BMS). They also lower the incidence of major adverse cardiac events (MACE)

• In 2022, the balloon-expanding stents segment accounted for the largest share of 53.92% of the market. Balloon-expanding stents provide a notable advantage by allowing precise and controlled expansion within the affected blood vessel. Furthermore, the increasing preference for minimally invasive procedures has greatly contributed to the growth of this segment

• In 2022, the Iliac artery stents segment accounted for the largest share of 33.46% of the market. Iliac arterial occlusive disease affects many individuals, including around 8 million people in the U.S.

• In 2022, the hospital & cardiac centers segment accounted for the largest share of 74.54% of the market. Hospital and cardiac centers are essential in diagnosing and treating CVDs, including conditions related to peripheral arterial disease

• In 2022, North America accounted for the largest share of 43.79% of the market. North America is home to a robust healthcare infrastructure with advanced medical facilities and skilled healthcare professionals, ensuring easy access to peripheral vascular stents for patients in the region

Peripheral Vascular Stents Market Segmentation

Grand View Research has segmented the global peripheral vascular stents market based on type, mode of delivery, product, end-use, and region:

Peripheral Vascular Stents Type Outlook (Revenue, USD Million, 2018 - 2030)

• Drug Eluting Stents (DES)

• Bare Metal Stents (BMS)

• Bioabsorbable Stents

Peripheral Vascular Stents Mode of Delivery Outlook (Revenue, USD Million, 2018 - 2030)

• Self-expanding Stents

• Balloon-expandable Stents

Peripheral Vascular Stents Product Outlook (Revenue, USD Million, 2018 - 2030)

• Iliac Artery Stents

• Femoral Artery Stents

• Carotid Artery Stents

• Renal Artery Stents

• Other Peripheral Stents

Peripheral Vascular Stents End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals & Cardiac Centers

• Ambulatory Surgical Centers

• Others

Peripheral Vascular Stents Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • U.K.

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • South Korea

  • Australia

  • Thailand

• Latin America

  • Brazil

  • Mexico

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in Peripheral Vascular Stents Market

• Boston Scientific Inc.

• Medtronic

• Terumo Medical

• Abbott

• Biotronik

• Lifetech

• iVascular SLU

• Stryker

• Cook Medical

• Microport Scientific Corporation

• Stentys S.A.

• Hellman & Friedman (Cordis Inc.)